CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Padagis US LLC recalls Nystatin Cream USP

Read the official FDA notice

Published
22 Jul 2026
Units affected
180,936 tubes
Agency
FDA
Country
United States

The hazard

Subpotent Drug: Low out of specification assay results performed during long-term stability testing.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35

Brand / company
Padagis US LLC
Codes / lots
Lot #: 205060, Exp 09/30/2027
Distribution
USA Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.